FDNA specializes in AI-powered image analysis and diagnostic tools aimed at expediting the identification of developmental and genetic disorders. Their technology is utilized in over 10,000 medical centers globally and is supported by more than 100 peer-reviewed publications. FDNA's offerings include a comprehensive digital platform that empowers parents, healthcare providers, and pharmaceutical companies to facilitate early detection and management of health conditions. The company’s data clearinghouse enhances interoperability among healthcare stakeholders, ensuring seamless communication and collaboration in patient care.

Central to FDNA's technology is its Multi-Modal Algorithm Framework, which integrates various algorithms to analyze health signals from multiple input modalities, including image analysis and natural language processing. Key algorithms such as Deep Gestalt® and Gestalt Matcher™ assist in mapping facial features to potential syndromes, while the Clinical Notes Analyzer extracts relevant health information from medical records. Additionally, tools like the D-Score™ and A-Score™ focus on identifying facial dysmorphology and characteristics associated with genetic conditions. Overall, FDNA's innovative approach significantly improves the accuracy and efficiency of diagnosing rare diseases and developmental delays, ultimately supporting better health outcomes for patients.

United States

FDNA uses facial analysis, deep learning and artificial intelligence to transform big data into actionable genomic intelligence to improve diagnostics and therapeutics.

FDNA

Company Details